Xiaosong Zhong
Overview
Explore the profile of Xiaosong Zhong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Gu A, An Z, Huang S, Zhang C, Zhong X, et al.
Hum Immunol
. 2024 Sep;
85(6):111093.
PMID: 39243423
Chimeric antigen receptor (CAR) T cell therapy is a powerful adoptive immunotherapy against blood cancers, but the therapeutic effect was not efficient enough on solid tumors. B cells have been...
2.
Zhong X, Ran X
Water Res
. 2024 Jun;
261:121995.
PMID: 38936237
Anthropogenic activities pose significant challenges to the accumulation of coastal nitrogen (N). Accurate identification of nitrate (NO) sources is thus essential for mitigating excessive N in many marginal seas. We...
3.
Yan Z, Xin Y, Zhong X, Yi Y, Li P, Wang Y, et al.
Water Res
. 2023 Dec;
249:120942.
PMID: 38043348
Estuaries are hotspots where terrestrially originated dissolved organic matter (DOM) is modified in molecular composition before entering marine environments. However, very few research has considered nitrogen (N) modifications of DOM...
4.
Huang S, Bai Y, An Z, Xu C, Zhang C, Wang F, et al.
Phytother Res
. 2023 Sep;
37(12):5947-5957.
PMID: 37748098
Therapy with chimeric antigen receptor T (CAR-T) cells involves using reformative T lymphocytes that have three domains, antigen recognition, transmembrane, and costimulating to achieve the therapeutic purpose. CAR-T therapy on...
5.
Yan Z, Xin Y, Zhong X, Yi Y, Li P, Wang Y, et al.
Water Res
. 2023 Aug;
244:120446.
PMID: 37572459
Marginal seas play a crucial role in the cycling of dissolved organic nitrogen (DON) between the terrestrial and marine environments. However, very few studies have considered the molecular transformation of...
6.
Liu J, Huang F, Liu J, Liu X, Lin R, Zhong X, et al.
Mar Life Sci Technol
. 2023 Jun;
5(2):257-270.
PMID: 37275536
Supplementary Information: The online version contains supplementary material available at 10.1007/s42995-023-00169-y.
7.
Gu A, Bai Y, Zhang C, Xu C, An Z, Zhang Y, et al.
Cancer Immunol Immunother
. 2023 Mar;
72(7):2393-2403.
PMID: 36991262
Chimeric antigen receptor (CAR)-modified T (CAR-T) cell therapy has been proven to be a powerful tool for the treatment of cancer, however, the limits are obvious, especially for solid tumors....
8.
Zhang Y, Zhuang Q, Wang F, Zhang C, Xu C, Gu A, et al.
J Transl Med
. 2022 Sep;
20(1):432.
PMID: 36167591
Background: Chimeric antigen receptor (CAR)-T cell therapy is a powerful adoptive immunotherapy against both B-cell malignancies and some types of solid tumors. Interleukin (IL) -15 is an important immune stimulator...
9.
Xu C, Bai Y, An Z, Hu Y, Zhang C, Zhong X
Mol Ther Oncolytics
. 2022 Feb;
24:443-451.
PMID: 35141400
Chimeric antigen receptor (CAR)-modified T cells have exhibited impressive anti-tumor effects in both B cell malignancies and some types of solid tumors. However, single-chain variable fragment (scFv) of a murine...
10.
Ren X, Wen W, Fan X, Hou W, Su B, Cai P, et al.
Cell
. 2021 Nov;
184(23):5838.
PMID: 34767776
No abstract available.